{
    "Allocation": "Randomized",
    "CompleteTime": 8,
    "DesignModel": "Crossover Assignment",
    "DrugInformation": {
        "ArmGroupList": [
            {
                "ArmGroupDescription": "s-1: 30 mg/m2 every 3 weeks , ",
                "ArmGroupLabel": "1",
                "ArmGroupType": "Experimental",
                "InterventionDescription": [
                    {
                        "Dosage": "30 mg/m2",
                        "DrugName": "s-1",
                        "Duration": "every 3 weeks",
                        "HowToTake": "",
                        "OtherName": []
                    }
                ],
                "InterventionList": {
                    "ArmGroupInterventionName": [
                        "drug: s-1"
                    ]
                }
            },
            {
                "ArmGroupDescription": "ft: 800 mg  , ",
                "ArmGroupLabel": "2",
                "ArmGroupType": "Active Comparator",
                "InterventionDescription": [
                    {
                        "Dosage": "800 mg",
                        "DrugName": "ft",
                        "Duration": "",
                        "HowToTake": "",
                        "OtherName": []
                    }
                ],
                "InterventionList": {
                    "ArmGroupInterventionName": [
                        "drug: ft"
                    ]
                }
            }
        ]
    },
    "Enrollment": "12",
    "InterventionName": "",
    "Masking": "None (Open Label)",
    "NCTID": "NCT00400023",
    "Objective": "A Phase 1, Open-Label, Randomized, Cross-Over, Pharmacokinetic Study Evaluating the Effect of S-1 on Advanced Solid Tumors",
    "OfficialTitle": "A Phase 1, Open-Label, Randomized, Cross-Over, Pharmacokinetic Study Evaluating the Effect of the Dihydropyrimidine Dehydrogenase (Dpd) Inhibitory Action of 5-Chloro-2,4-Dihydroxypyridine (Cdhp) as an S-1 Component",
    "PopulationBox": {
        "Condition": "Tumors",
        "Gender": "All",
        "HealthyCondition": "No",
        "MaxAge": "",
        "MinAge": "18 Years",
        "Participant": "12"
    },
    "PopulationRatio": "",
    "Title": "A Phase 1, Open-Label, Randomized, Cross-Over, Pharmacokinetic Study Evaluating the Effect of S-1 on Advanced Solid Tumors",
    "WashoutPeriod": "1-week",
    "_id": "NCT00400023",
    "version": "1.7.1"
}